Pierre Sayad - Chief Medical Officer at Fennec Pharmaceuticals Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Options	150K	$635K	$4.23	Nov 13, 2024	Direct	Common Shares

Showing 1 to 1 of 1 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.